Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02067507 · ClinicalTrials.gov registry record · NA

Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
53,414
Enrollment target

NCT02067507 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 53,414 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02067507, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
53,414 participants
Enrollment target

Study Summary

The primary aim of the project is to increase human papillomavirus (HPV) vaccine receipt rates among low-income, ethnic minority adolescents (girls and boys 11-17 years of age) in Los Angeles County. We will accomplish this goal by implementing and rigorously evaluating interventions in multiple venues that serve our target population, including the Los Angeles County Department of Public Health (LACDPH) and two large Federally Qualified Health Centers (FQHCs). Our hypotheses are: Primary hypothesis: 1. The intervention group will have a higher rate of HPV vaccine initiation at follow-up compared to the control group. Secondary hypothesis: 2. The intervention group will have higher vaccine completion rates (3 doses) at follow-up compared to the control group.

Interventions

  • BEHAVIORAL Tailored education and referral
  • BEHAVIORAL Staff training and patient reminders
  • BEHAVIORAL Clinic-level reminder systems

Trial Details

FieldValue
Enrollment Target 53,414 participants
Start Date 2012-06
Est. Completion 2019-10
Phase NA

What the Registry Record Tells You About NCT02067507

The ClinicalTrials.gov registry entry for NCT02067507 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53,414 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Tailored education and referral is the first listed.

NCT02067507 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02067507 about?

NCT02067507 is a clinical study titled "Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County". The primary aim of the project is to increase human papillomavirus (HPV) vaccine receipt rates among low-income, ethnic minority adolescents (girls and boys 11-17 years of age) in Los Angeles County. We will accomplish this goal by implementing and rigorously evaluating interventions in multiple ven...

What is the current status of trial NCT02067507?

This trial is currently completed. It is a NA study. The enrollment target is 53,414 participants. The study started on 2012-06. Estimated completion is 2019-10.

What interventions are being tested in trial NCT02067507?

The interventions under investigation include: Tailored education and referral (BEHAVIORAL), Staff training and patient reminders (BEHAVIORAL), Clinic-level reminder systems (BEHAVIORAL).

Who is sponsoring clinical trial NCT02067507?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.